Difference between revisions of "2011 Group Project 2"

From Embryology
Line 2: Line 2:
  
  
 +
== Introduction==
  
 +
==Historical Background==
  
----
+
==Epidemiology==
  
'''Duchennes Muscular dystrophy'''
+
==Etiology==
  
----
+
== Pathogenesis==
--[[User:Z3288827|z3288827]] 21:53, 8 August 2011 (EST)
 
  
== Review Article ==
+
== Dianostic Tests==
Hey guys, just found a review article that I thought was rather interesting, it's an animal model for Duchenne's muscular dystrophy[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022202/]. I also found a primary journal article that discusses drug delivery for the condition [http://www.jstage.jst.go.jp/article/bpb/34/5/712/_pdf]. I will print these articles for myself tonight and give them a quick read tomorrow and then paste a quick summary of the articles here just for you guys to consider :)
 
  
== References ==
+
==Clinical Manifestations==
[1] Nakamura A., Takeda S.; Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic Applications, J. Biomedicine and Biotechnology Vol. 2011, Article ID 184393
 
  
[2] Yukihara et al; Effective Drug Delivery System for Duchenne Muscular Dystrophy Using Hybrid Liposomes Including Gentamicin along with Reduced Toxicity, J. Biol. Pharm. Bull, Volume 34, No. 5 pp. 712-716
+
== Treatment==
  
 +
==Further research possibilities==
 +
 +
==Glossary==
 +
 +
==References==
 +
<references/>
  
  
 
{{2011Projects}}
 
{{2011Projects}}

Revision as of 08:10, 16 August 2011